US Bancorp
NDRM

US Bancorp’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

US Bancorp’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,000
Closed -$15K – 3846
2015
Q2 		$15K Hold
1,000
– – ﹤0.01% 3041
2015
Q1 		$13K Hold
1,000
– – ﹤0.01% 3075
2014
Q4 		$14K Buy
+1,000
New +$7.91K ﹤0.01% 3022

Other funds holding NDRM

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

US Bancorp's NDRM Position: Q3 2015 in Review

US Bancorp sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q3 2015, closing a stake of 1,000 shares — an estimated $15K sold.

US Bancorp first reported a position in NDRM in Q4 2014 and held it in 3 quarters. The position peaked at $15K in Q2 2015. 41 funds tracked by Wall St. Rank hold NDRM as of Q3 2015.

  • US Bancorp reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q3 2015 after selling out during the quarter.
  • US Bancorp sold 1,000 NeuroDerm Ltd. Ordinary Shares shares in Q3 2015, an estimated $15K.
  • US Bancorp first reported a position in NeuroDerm Ltd. Ordinary Shares in Q4 2014 and held it in 3 quarters.
  • US Bancorp's NeuroDerm Ltd. Ordinary Shares position peaked at $15K in Q2 2015.
  • 41 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q3 2015.

Based on US Bancorp's 13F filing for Q3 2015, filed 16 Nov 2015.